Stock listing

Anixa Biosciences, Inc.

Selected listing: ANIX · NASDAQ · USD · US

Anixa Biosciences, Inc. (NASDAQ:ANIX), Health Technology. Latest release Oct 5, 2026: Anixa Biosciences Announces First Case of Stable Disease for Three…

ANIX:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:ANIX
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Anixa Biosciences, Inc.

Anixa Biosciences, Inc. is a public company traded under the ticker ANIX in the American market. Anixa focuses on developing innovative therapies and technologies in the biosciences sector.

Latest news from Anixa Biosciences, Inc.

Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial

October 5, 2026

Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial

October 4, 2026

Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial

October 1, 2026

Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial

September 30, 2026

Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040

September 21, 2026

All Anixa Biosciences, Inc. news →

Research Anixa Biosciences, Inc.

Anixa Biosciences, Inc. company profile

View the public company page for Anixa Biosciences, Inc. on 6ix.

Anixa Biosciences, Inc. news

Read company news and market updates connected to Anixa Biosciences, Inc..

Anixa Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Anixa Biosciences, Inc..